Clinical Trials Logo

Clinical Trial Summary

The dissemination of individual tumor cells is a common phenomenon in solid cancers. Detection of tumor cells in peripheral blood circulating tumor cells (CTC) in nonmetastatic situation is of high prognostic significance.

The objective of our study was to detect circulating tumor cells in two different method in patient with head and neck squamous cell carcinoma .


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02892786
Study type Interventional
Source Institut de Cancérologie de Lorraine
Contact
Status Completed
Phase N/A
Start date December 8, 2010
Completion date April 2018

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02572869 - Functional and Aesthetic Outcomes After Mandible Reconstruction With Fibula Osteomyocutaneous Free Flaps N/A
Active, not recruiting NCT02823574 - Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Phase 2
Not yet recruiting NCT03589339 - NBTXR3 Activated by SABR for Patients With Advanced HNSCC or NSCLC Treated With an Anti-PD1 Antibody Phase 1/Phase 2
Withdrawn NCT03238638 - A Study of Epacadostat + Pembrolizumab in Head and Neck Cancer Patients, Who Failed Prior PD-1/PD-L1 Therapy Phase 2
Not yet recruiting NCT03607227 - Continous Popliteal Block for Microvascular Free Flap Reconstruction in Ear, Nose and Throat Surgery Phase 4
Not yet recruiting NCT03266276 - Assessing Impact of CCO's PSO & PC Pathway in Ambulatory HNC Clinics N/A
Recruiting NCT03302676 - The Use of Chewing Gum for Xerostomia and Hyposalivation After Radiotherapy for Oral and Oropharyngeal Tumors Phase 3
Recruiting NCT02903914 - Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors Phase 1/Phase 2
Not yet recruiting NCT02875795 - Carcinologic Speech Severity Index N/A
Recruiting NCT02308072 - Phase I Study of Olaparib Combined With Cisplatin-based Chemoradiotherapy to Treat Locally Advanced Head and Neck Cancer Phase 1
Recruiting NCT02546895 - Prospective Registration of Head and Neck Cancer
Active, not recruiting NCT02526017 - Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers Phase 1
Completed NCT02554968 - Reliability and Validity of Patient Reported Outcome Measures in Head and Neck Cancer
Recruiting NCT02489084 - Predictive Models for Radiation-induced Side Effects in Head and Neck Cancer Based on Single Nucleotide Polymorphisms (SNP) N/A
Recruiting NCT02017509 - Immunoscore in Rectal Cancer N/A
Active, not recruiting NCT01895829 - Ferumoxytol - Iron Oxide Nanoparticle Magnetic Resonance Dynamic Contrast Enhanced MRI Early Phase 1
Completed NCT01952821 - Validity and Reliability of Outcome Measures in Patients With Cancer of the Head and Neck N/A
Completed NCT02038114 - The Impact of a Patient Education Intervention for Ambulatory Oncology Patients N/A
Completed NCT02921984 - Concurrent Chemotherapy Based on Genetic Testing in Patients With High-Risk Salivary Gland Tumors Phase 1
Completed NCT01955239 - Parotid-gland Stem-cell Sparing Intensity-modulated Radiotherapy N/A